Literature DB >> 28921268

Effects of bupivacaine and lidocaine on cardiac function in awake and pentobarbital-anesthetized rats.

Satoshi Kashimoto1, Marie-Françoise Doursout2, Patrick Wouters3, Takeshi Oguchi1.   

Abstract

Using an implanted Doppler crystal, we evaluated emodynamic changes induced by subconvulsive doses of bupivacaine and lidocaine in awake and pentobarbitalanesthetized rats. Low doses of lidocaine (2.0 mg·kg-1) and bupivacaine (0.5 mg·kg-1) changed hemodynamics minimally. However, a high dose of lidocaine (8.0 mg·kg-1) reduced heart rate, cardiac output, and regional myocardial wall thickening for a short period with or without anesthesia. In contrast, a high dose of bupivacaine (2.0 mg·kg-1) increased mean arterial pressure and did not change heart rate or regional myocardial wall thickening in the awake state. Under pentobarbital anesthesia, a high dose of lidocaine reduced mean arterial pressure significantly shortly after the injection, but bupivacaine did not. Thus, it is unlikely that bupivacaine has more potent cardiotoxicity than lidocaine in subconvulsive doses.

Entities:  

Keywords:  Bupivacaine; Cardiac function; Heart; Lidocaine; Local anesthetics

Year:  1997        PMID: 28921268     DOI: 10.1007/BF02480003

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  27 in total

1.  Depression of myocardial contractility in vitro by bupivacaine, etidocaine, and lidocaine.

Authors:  C Lynch
Journal:  Anesth Analg       Date:  1986-06       Impact factor: 5.108

2.  Functional and metabolic effects of bupivacaine and lidocaine in the perfused working rat heart.

Authors:  L H Cronau; R G Merin; E Abouleish; M Steenberg; A B Melgarejo
Journal:  Anesth Analg       Date:  1988-10       Impact factor: 5.108

3.  An ultrasonic pulsed Doppler system for measuring blood flow in small vessels.

Authors:  C J Hartley; J S Cole
Journal:  J Appl Physiol       Date:  1974-10       Impact factor: 3.531

4.  Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole.

Authors:  C W Clarkson; L M Hondeghem
Journal:  Anesthesiology       Date:  1985-04       Impact factor: 7.892

5.  Comparative direct effects of lidocaine and bupivacaine on regional myocardial function in dogs at noncardiovascular toxic levels.

Authors:  Y Fujita
Journal:  Anesth Analg       Date:  1994-06       Impact factor: 5.108

6.  Lidocaine and bupivacaine cardiorespiratory toxicity is additive: a study in rats.

Authors:  B Mets; P K Janicki; M F James; R Erskine; B Sasman
Journal:  Anesth Analg       Date:  1992-10       Impact factor: 5.108

7.  Comparative cardiotoxicity of bupivacaine and lidocaine in the isolated perfused mammalian heart.

Authors:  R D Tanz; T Heskett; R W Loehning; C A Fairfax
Journal:  Anesth Analg       Date:  1984-06       Impact factor: 5.108

8.  Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep.

Authors:  C Nancarrow; A J Rutten; W B Runciman; L E Mather; R J Carapetis; C F McLean; S F Hipkins
Journal:  Anesth Analg       Date:  1989-09       Impact factor: 5.108

9.  Differential depressant and electrophysiologic cardiotoxicity of local anesthetics: an experimental study with special reference to lidocaine and bupivacaine.

Authors:  S Nath; S Häggmark; G Johansson; S Reiz
Journal:  Anesth Analg       Date:  1986-12       Impact factor: 5.108

10.  Toxicity and resuscitation in lidocaine- or bupivacaine-infused cats.

Authors:  H S Chadwick
Journal:  Anesthesiology       Date:  1985-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.